newsfilter
← Latest News
GlobeNewswire·

Agomab to Participate in Upcoming Investor Conferences

Antwerp, Belgium, September 3, 2026 – Agomab Therapeutics NV (NASDAQ:AGMB) ("Agomab"), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management